Caris Life Sciences, Inc.
For the period ended Jun 4, 2026. Filed Apr 23, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 4, 2026 · Filed Apr 23, 2026
CAI$25.23-3.1%Stored close · as of Nov 6, 2026
Contents
Proxy Summary
This summary highlights information contained elsewhere in this Proxy Statement. This summary does not contain all of the information that you should consider, and you should read the entire Proxy Statement carefully before voting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.